サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1750720

免疫組織化学の市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年

Immunohistochemistry Market Size, Share & Trends Analysis Report By Product (Antibodies, Equipment, Reagents, Kits), By Application (Diagnostics, Research), By End use (Hospitals & Diagnostic Laboratories), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.72円
免疫組織化学の市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年
出版日: 2025年05月16日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

免疫組織化学市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の免疫組織化学市場規模は2030年までに35億米ドルに達すると推定され、2025年から2030年までのCAGRは6.93％で成長すると予測されています。

正確なデータに対する高い要求が、IHC技術におけるいくつかの技術的進歩を促し、その結果、正確で文脈に沿ったデータ分析が提供されるようになりました。マルチプレックスIHC、計算病理学、次世代IHCなどの先端技術の出現が世界市場を牽引しています。免疫組織化学プロトコールは臨床病理学、特に腫瘍病理学、血液病理学、神経病理学のサブスペシャリティにおいて人気を博しています。

この技術はがん診断の形成に重要な役割を果たしています。したがって、がんの有病率の増加はIHCの需要を増加させ、市場の成長に寄与すると予想されます。さらに、創薬および開発活動におけるIHCの幅広い応用範囲は、予測期間中の収益成長を押し上げると予想されます。ホールスライドイメージングとデジタル画像解析は、高精度で客観的な評価を提供します。そのため、画像解析は、薬剤の再配置、標的の検証、患者の層別化、バイオマーカー発現研究、薬剤の有効性と安全性研究など、創薬のさまざまな局面で利用することができます。

この領域がもたらす収益機会を認識し、業界の事業会社は市場での存在感を高めるための戦略的取り組みを続けています。例えば、2021年6月、PathAIはアストラゼネカおよび第一三共と共同で、乳がんサンプルのHER2 IHC画像の自動定量化を可能にする機械学習ベースのモデルを作成しました。世界市場は、先進国および新興国での高齢者人口の増加から恩恵を受けると思われます。世界の老年人口が増加するにつれ、加齢関連疾患の有病率は急激に上昇すると予測されます。

免疫組織化学市場のハイライト

  • 疾患診断や薬剤検査のワークフローで実施される免疫組織化学アッセイに抗体が多く使用されていることから、2024年には抗体製品セグメントが市場をリードしました。
  • 診断アプリケーション分野は、診断現場でIHC検査が広く応用されていることから、2024年の市場をリードしました。
  • 薬剤検査分野は予測期間中に大きな成長が見込まれます。これは、製薬企業による新薬の研究開発への投資が増加しているためです。
  • 2024年には、病院と診断ラボの最終用途セグメントが最大の収益シェアを占めました。研究機関では、創薬活動のためにIHCの採用が増加しているため、予測期間中に最も速いCAGRを記録すると予想されます。
  • 北米は、がん罹患率の高さ、主要プレイヤーの存在、医療・バイオテクノロジー分野の発展といった複数の要因が重なり、2024年に最大の地域市場に浮上しました。
  • アジア太平洋地域は、予測期間中に最も速いCAGRで成長すると予測されており、中国が最も急成長している市場です。中国における規制当局の承認の増加と新規IHCソリューションの発売が、同国の市場成長を加速させています。
  • 主要企業は、市場での地位を強化し、競争上の優位性を獲得するために、集中的な取り組みを行っています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 免疫組織化学市場の変数、動向、範囲

  • 市場イントロダクション/系統展望
  • 市場規模と成長見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 免疫組織化学市場分析ツール
    • ポーター分析
    • PESTEL分析

第4章 免疫組織化学市場：製品別　推定・動向分析

  • セグメントダッシュボード
  • 免疫組織化学市場：製品変動分析、2024年および2030年
  • 抗体
    • 一次抗体
    • 二次抗体
  • 装置
    • スライド染色システム
    • 組織マイクロアレイ
    • 組織処理システム
    • スライドスキャナー
    • その他
  • 試薬
    • 組織学的染色
    • ブロッキング血清と試薬
    • 発色基質
    • 固定試薬
    • 安定剤
    • 有機溶剤
    • タンパク質分解酵素
    • 希釈剤
  • キット

第5章 免疫組織化学市場：用途別　推定・動向分析

  • セグメントダッシュボード
  • 免疫組織化学市場：用途変動分析、2024年および2030年
  • 診断
    • がん
    • 感染症
    • 心血管疾患
    • 自己免疫疾患
    • 糖尿病
    • 腎臓疾患
  • 調査

第6章 免疫組織化学市場：最終用途別　推定・動向分析

  • セグメントダッシュボード
  • 免疫組織化学市場：最終用途変動分析、2024年および2030年
  • 病院および診断検査室
  • 調査機関
  • その他

第7章 免疫組織化学市場：地域別　推定・動向分析

  • 免疫組織化学市場シェア、地域別、2024年および2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東およびアフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業分類
  • 企業ヒートマップ分析
  • 企業プロファイル
    • Thermo Fisher Scientific Inc.
    • F. Hoffmann-La Roche Ltd.
    • Merck KGaA
    • Danaher Corporation
    • PerkinElmer Inc.
    • Bio-Rad Laboratories, Inc.
    • Cell Signaling Technology, Inc.
    • Bio SB
    • Agilent Technologies, Inc.
    • Abcam Limited.
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global Immunohistochemistry market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global Immunohistochemistry market, by End use, 2018 - 2030 (USD Million)
  • Table 6 North America Immunohistochemistry market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 8 North America Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 9 North America Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S. Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 11 U.S. Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 14 Canada Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 17 Mexico Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe Immunohistochemistry market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 21 Europe Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 23 UK Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 24 UK Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 25 UK Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Germany Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 27 Germany Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 28 Germany Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 30 France Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 31 France Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 33 Italy Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 34 Italy Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 36 Spain Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Denmark Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 39 Denmark Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 40 Denmark Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Sweden Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 42 Sweden Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 43 Sweden Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Norway Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 45 Norway Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 46 Norway Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Immunohistochemistry market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Japan Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 52 Japan Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 53 Japan Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 54 China Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 55 China Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 56 China Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 57 India Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 58 India Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 59 India Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Australia Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 61 Australia Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 62 Australia Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 63 South Korea Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 64 South Korea Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 65 South Korea Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Thailand Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 67 Thailand Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 68 Thailand Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America Immunohistochemistry market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 71 Latin America Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 72 Latin America Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Brazil Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 74 Brazil Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 75 Brazil Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 77 Argentina Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 78 Argentina Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 79 MEA Immunohistochemistry market, by country, 2018 - 2030 (USD Million)
  • Table 80 MEA Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 81 MEA Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 82 MEA Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 83 South Africa Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 84 South Africa Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 85 South Africa Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 89 UAE Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 90 UAE Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 91 UAE Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Immunohistochemistry market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Immunohistochemistry market: Product outlook key takeaways
  • Fig. 20 Immunohistochemistry market: Product movement analysis
  • Fig. 21 Antibodies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Primary Antibodies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Secondary Antibodies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Equipment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Slide Staining System market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Tissue Microarrays market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Tissue Processing Systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Slide Scanners market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Histological stains market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Blocking Sera and Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Chromogenic Substrates market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Fixation Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Stabilizers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Organic Solvents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Proteolytic Enzymes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Diluents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Immunohistochemistry market: Application outlook key takeaways
  • Fig. 41 Immunohistochemistry market: Application movement analysis
  • Fig. 42 Infectious disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Infectious Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Cardiovascular Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Autoimmune Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Diabetes Mellitus market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Nephrological Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Research market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Immunohistochemistry market: End-use outlook key takeaways
  • Fig. 52 Immunohistochemistry market: End use movement analysis
  • Fig. 53 Hospitals & Diagnostic Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Research Institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Regional marketplace outlook, 2024 & 2030 (USD million)
  • Fig. 57 Regional marketplace: Key takeaways
  • Fig. 58 North America Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 U.S. Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Canada Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Mexico Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Europe Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 UK Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Germany Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 France Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Spain Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Italy Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Denmark Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Sweden Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Norway Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Asia Pacific Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Japan Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 China Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 India Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Australia Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 South Korea Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 Thailand Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 Market participant categorization
  • Fig. 97 Immunohistochemistry market position analysis, 2024
  • Fig. 98 Strategic framework
目次
Product Code: GVR-1-68038-718-6

Immunohistochemistry Market Growth & Trends:

The global immunohistochemistry market size is estimated to reach USD 3.50 billion by 2030, registering to grow at a CAGR of 6.93% from 2025 to 2030 according to a new report by Grand View Research, Inc. The high demand for accurate data has driven several technological advancements in IHC techniques, resulting in the delivery of precise and contextual data analyses. The emergence of advanced techniques, such as multiplex IHC, computational pathology, and next-generation IHC, is driving the global market. Immunohistochemistry protocols have gained popularity in clinical pathology, especially in the subspecialties of oncologic pathology, hematopathology, and neuropathology.

The technique has played a vital role in shaping cancer diagnostics. Thus, the growing prevalence of cancer is expected to increase the demand for IHC, thus contributing to market growth. Furthermore, the wide application scope of IHC in drug discovery and development activities is expected to boost revenue growth over the forecast period. Whole slide imaging and digital image analysis offer highly accurate and objective evaluations. Thus, image analysis can be used across different aspects of drug discovery including drug repositioning, target validation, patient stratification, biomarker expression studies, and drug efficacy & safety studies.

Acknowledging the profitable opportunities posed by the space, operating players in the industry continue to undertake strategic initiatives to strengthen their market presence. For instance, in June 2021, PathAI, in collaboration with AstraZeneca and Daiichi Sankyo Company Ltd., created machine learning-based models to enable automated quantification of HER2 IHC images in breast cancer samples. The global market will benefit from the growing geriatric population in developed and developing nations. As the global geriatric population increases, the prevalence of age-related illnesses is predicted to rise drastically.

Immunohistochemistry Market Report Highlights:

  • The antibodies product segment led the market in 2024 owing to the high use of antibodies for immunohistochemistry assays carried out for disease diagnosis and drug testing workflows
  • The diagnostics application segment led the market in 2024 owing to the widespread application of IHC tests in diagnostic settings
  • The drug testing segment is expected to witness significant growth during the forecast period. This is due to increasing investment flow by pharmaceutical companies in R&D activities of novel drug discovery and development
  • The hospitals and diagnostic laboratories end-use segment accounted for the largest revenue share in 2024. Research institutes are expected to register the fastest CAGR over the forecast period owing to the increasing adoption of IHC in research institutes for drug discovery activities
  • North America emerged as the largest regional market in 2024 owing to the confluence of multiple factors, such as high cancer prevalence, presence of key players, and developed healthcare & biotechnological sectors
  • The Asia Pacific is projected to grow at the fastest CAGR over the forecast period with China being the fastest-growing market. Increasing regulatory approvals and the launch of novel IHC solutions in China are accelerating the country's market growth
  • Key players are engaged in making focused attempts to reinforce their market position and gain a competitive advantage

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Immunohistochemistry Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Immunohistochemistry Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Immunohistochemistry Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Immunohistochemistry Market: Product Movement Analysis, 2024 & 2030 (USD Million)
  • 4.3. Antibodies
    • 4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Primary Antibodies
      • 4.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Secondary Antibodies
      • 4.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Equipment
    • 4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Slide Staining System
      • 4.4.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Tissue Microarrays
      • 4.4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Tissue Processing Systems
      • 4.4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Slide Scanners
      • 4.4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.6. Others
      • 4.4.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Reagents
    • 4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Histological stains
      • 4.5.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Blocking Sera and Reagents
      • 4.5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Chromogenic Substrates
      • 4.5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.5. Fixation Reagents
      • 4.5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.6. Stabilizers
      • 4.5.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.7. Organic Solvents
      • 4.5.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.8. Proteolytic Enzymes
      • 4.5.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.9. Diluents
      • 4.5.9.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Kits
    • 4.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Immunohistochemistry Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Immunohistochemistry Market: Application Movement Analysis, 2024 & 2030 (USD Million)
  • 5.3. Diagnostics
    • 5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. Cancer
      • 5.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Infectious Diseases
      • 5.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. Cardiovascular Diseases
      • 5.3.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.5. Autoimmune Diseases
      • 5.3.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.6. Diabetes Mellitus
      • 5.3.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.7. Nephrological Diseases
      • 5.3.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Research
    • 5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Immunohistochemistry Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Immunohistochemistry Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
  • 6.3. Hospitals & Diagnostic Laboratories
    • 6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Research Institutes
    • 6.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Immunohistochemistry Market: Regional Estimates & Trend Analysis

  • 7.1. Immunohistochemistry Market Share, By Region, 2024 & 2030 (USD Million)
  • 7.2. North America
    • 7.2.1. North America Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Norway Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Japan Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. China Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Australia Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. South Korea
      • 7.4.6.1. South Korea Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. South Africa Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. UAE Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Thermo Fisher Scientific Inc.
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. F. Hoffmann-La Roche Ltd.
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Merck KGaA
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Danaher Corporation
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. PerkinElmer Inc.
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Bio-Rad Laboratories, Inc.
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. Cell Signaling Technology, Inc.
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. Bio SB
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Agilent Technologies, Inc.
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Abcam Limited.
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives